These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16260424)

  • 1. Interdependence of lean body mass and total body water, but not quality of life measures, during low dose GH replacement in GH-deficient adults.
    Mukherjee A; Adams JE; Smethurst L; Shalet SM
    Eur J Endocrinol; 2005 Nov; 153(5):661-8. PubMed ID: 16260424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Body composition and quality of life in adults with growth hormone deficiency; effects of low-dose growth hormone replacement.
    Ahmad AM; Hopkins MT; Thomas J; Ibrahim H; Fraser WD; Vora JP
    Clin Endocrinol (Oxf); 2001 Jun; 54(6):709-17. PubMed ID: 11422104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose titration and patient selection increases the efficacy of GH replacement in severely GH deficient adults.
    Murray RD; Skillicorn CJ; Howell SJ; Lissett CA; Rahim A; Shalet SM
    Clin Endocrinol (Oxf); 1999 Jun; 50(6):749-57. PubMed ID: 10468947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influences on quality of life in GH deficient adults and their effect on response to treatment.
    Murray RD; Skillicorn CJ; Howell SJ; Lissett CA; Rahim A; Smethurst LE; Shalet SM
    Clin Endocrinol (Oxf); 1999 Nov; 51(5):565-73. PubMed ID: 10594517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replacement treatment with biosynthetic human growth hormone in growth hormone-deficient hypopituitary adults.
    Beshyah SA; Freemantle C; Shahi M; Anyaoku V; Merson S; Lynch S; Skinner E; Sharp P; Foale R; Johnston DG
    Clin Endocrinol (Oxf); 1995 Jan; 42(1):73-84. PubMed ID: 7889635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using dilution techniques and multifrequency bioelectrical impedance to assess both total body water and extracellular water at baseline and during recombinant human growth hormone (GH) treatment in GH-deficient adults.
    Janssen YJ; Deurenberg P; Roelfsema F
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3349-55. PubMed ID: 9329367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH-binding protein, body mass index, age, and gender.
    Johannsson G; Bjarnason R; Bramnert M; Carlsson LM; Degerblad M; Manhem P; Rośen T; Thorén M; Bengtsson BA
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1575-81. PubMed ID: 8636370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seven years of growth hormone (GH) replacement improves quality of life in hypopituitary patients with adult-onset GH deficiency.
    Elbornsson M; Horvath A; Götherström G; Bengtsson BÅ; Johannsson G; Svensson J
    Eur J Endocrinol; 2017 Feb; 176(2):99-109. PubMed ID: 27803031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The characteristics of quality of life impairment in adult growth hormone (GH)-deficient survivors of cancer and their response to GH replacement therapy.
    Mukherjee A; Tolhurst-Cleaver S; Ryder WD; Smethurst L; Shalet SM
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1542-9. PubMed ID: 15613427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Total body composition in adult patients with growth hormone deficiency before and after its administration].
    Weiss V; Krsek M; Marek J; Stĕpán J; Malík J
    Vnitr Lek; 2003 Aug; 49(8):650-5. PubMed ID: 14518091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of growth hormone status on body composition and the skeleton.
    Mukherjee A; Murray RD; Shalet SM
    Horm Res; 2004; 62 Suppl 3():35-41. PubMed ID: 15539797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of continuation or cessation of growth hormone (GH) therapy on body composition and metabolic status in adolescents with severe GH deficiency at completion of linear growth.
    Carroll PV; Drake WM; Maher KT; Metcalfe K; Shaw NJ; Dunger DB; Cheetham TD; Camacho-Hübner C; Savage MO; Monson JP
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3890-5. PubMed ID: 15292323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life, body composition and muscle strength in adult growth hormone deficiency: the influence of growth hormone replacement therapy for up to 3 years.
    Wallymahmed ME; Foy P; Shaw D; Hutcheon R; Edwards RH; MacFarlane IA
    Clin Endocrinol (Oxf); 1997 Oct; 47(4):439-46. PubMed ID: 9404442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections.
    Amato G; Mazziotti G; Di Somma C; Lalli E; De Felice G; Conte M; Rotondi M; Pietrosante M; Lombardi G; Bellastella A; Carella C; Colao A
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3720-5. PubMed ID: 11061530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of growth hormone in the regulation of erythropoiesis, red cell mass, and plasma volume in adults with growth hormone deficiency.
    Christ ER; Cummings MH; Westwood NB; Sawyer BM; Pearson TC; Sönksen PH; Russell-Jones DL
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2985-90. PubMed ID: 9284731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairment of anaerobic capacity in adults with growth hormone deficiency.
    Chikani V; Cuneo RC; Hickman I; Ho KK
    J Clin Endocrinol Metab; 2015 May; 100(5):1811-8. PubMed ID: 25695894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone (GH) replacement therapy in GH deficient adults: predictors of one-year metabolic and clinical response.
    Svensson J; Finer N; Bouloux P; Bevan J; Jonsson B; Mattsson AF; Lundberg M; Harris PE; Koltowska-Häggström M; Monson JP;
    Growth Horm IGF Res; 2007 Feb; 17(1):67-76. PubMed ID: 17223598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 18 months of GH replacement on cardiovascular risk factors and quality of life in GH deficient adults; a randomized controlled trial using a fixed very low and a standard dose of GH.
    Götherström G; Johannsson G; Svensson J
    Growth Horm IGF Res; 2022 Dec; 67():101510. PubMed ID: 36240610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term challenges in growth hormone treatment.
    Leal Cerro A
    Horm Res; 2004; 62 Suppl 4():23-30. PubMed ID: 15591763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.